Form 8-K - Current report:
SEC Accession No. 0001213900-14-001680
Filing Date
2014-03-24
Accepted
2014-03-24 17:15:06
Documents
3
Period of Report
2014-03-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k032414b_actiniumpharm.htm 8-K 20727
2 PRESS RELEASE f8k032414bex99_actiniumpharm.htm EX-99.1 11149
3 f8k032414bex99_actiniumpharm.jpg GRAPHIC 4017
  Complete submission text file 0001213900-14-001680.txt   38729
Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52446 | Film No.: 14713839
SIC: 6770 Blank Checks